.Basilea Pharmaceutica's work building brand new antifungals has actually obtained a substantial imp...
.Having currently gathered up the united state legal rights to Capricor Therapeutics' late-stage Duc...
.After pushing the choice meeting for Applied Therapeutics' metabolic condition medication govoresta...
.Novo Nordisk is continuing its press in to hereditary medications, agreeing to pay NanoVation Rehab...
.Innovent Biologics has helped make the instance that its gate inhibitor-cytokine fusion healthy pro...
.A stage 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) h...
.5 months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has actual...
.Ascendis Pharma has emerged as a possible threat to BioMarin's Voxzogo, stating period 3 growth ail...
.Though Alkeus Pharmaceuticals' oral eye ailment possession neglected to considerably decrease geogr...
.With a triad of biotechs reaching the Nasdaq on Friday, it was actually quick and easy to skip a sm...
.Immune gate inhibitors are the superheroes of cancer cells therapy. Drugs like Bristol Myers Squibb...
.Invite to recently's Chutes & Ladders, our summary of notable leadership hirings, firings as wel...
.Regeneron is back along with long-lasting follow-up for its own LAG-3 inhibitor and also PD-1 inhib...
.AstraZeneca has actually shared a very early look at the performance of its own in-house antibody-d...
.After announcing a stage 3 launch based upon favorable midstage end results, iTeos and also GSK are...
.The FDA should be more available as well as collaborative to unleash a surge in approvals of unusua...
.It's an unusually active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara T...
.Atea Pharmaceuticals' antiviral has actually stopped working another COVID-19 trial, however the bi...
.Neurocrine Biosciences' schizophrenia plan pivot has fallen short. The biotech was not able to imit...
.Sanofi has actually made a late entry to the radioligand celebration, paying out one hundred thousa...